Literature DB >> 3081184

Myopathy after short term administration of procainamide.

C A Lewis, N Boheimer, P Rose, G Jackson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3081184      PMCID: PMC1339571          DOI: 10.1136/bmj.292.6520.593

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  5 in total

1.  PATHOLOGICAL CHANGES IN SKIN AND SKELETAL MUSCLE FOLLOWING ALTERNATING CURRENT AND CAPACITOR DISCHARGE.

Authors:  G T SMITH; R BEEUWKES; M TOMKIEWICZ; T ABE; B LOWN
Journal:  Am J Pathol       Date:  1965-07       Impact factor: 4.307

2.  Procainamide dosage schedules, plasma concentrations, and clinical effects.

Authors:  J Koch-Weser; S W Klein
Journal:  JAMA       Date:  1971-03-01       Impact factor: 56.272

3.  Criteria for journal reports of suspected drug reactions.

Authors:  J K Jones
Journal:  Clin Pharm       Date:  1982 Nov-Dec

4.  Procainamide-induced myositis.

Authors:  E S Fontiveros; W J Cumming; P Hudgson
Journal:  J Neurol Sci       Date:  1980-02       Impact factor: 3.181

5.  Cerebellar ataxia due to procainamide toxicity.

Authors:  A B Schwartz; S C Klausner; S Yee; M Turchyn
Journal:  Arch Intern Med       Date:  1984-11
  5 in total
  2 in total

Review 1.  Poisoning due to class IA antiarrhythmic drugs. Quinidine, procainamide and disopyramide.

Authors:  S Y Kim; N L Benowitz
Journal:  Drug Saf       Date:  1990 Nov-Dec       Impact factor: 5.606

Review 2.  Toxic myopathies.

Authors:  Mamatha Pasnoor; Richard J Barohn; Mazen M Dimachkie
Journal:  Neurol Clin       Date:  2014-08       Impact factor: 3.806

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.